Nanochemistry plays a pivotal role in the pharmaceutical field, revolutionizing drug delivery and therapeutic strategies. At the nanoscale, materials exhibit unique properties that can be harnessed to enhance drug efficacy, bioavailability, and targeted delivery. Nanoparticles, liposomes, and nanocarriers are among the key innovations in nanochemistry that have gained prominence in pharmaceutical research. These nanoscale systems offer advantages such as increased drug solubility, prolonged circulation time, and specific targeting to diseased tissues. In drug formulation, nanochemistry allows for the precise control of particle size and surface characteristics, influencing the pharmacokinetics and pharmacodynamics of therapeutic agents.
Moreover, nanomaterials enable the co-delivery of multiple drugs, addressing the complexities of combination therapy. The development of nanoscale drug delivery systems has also contributed to minimizing side effects and improving patient compliance. As nanochemistry continues to advance, it holds the promise of optimizing pharmaceutical formulations, enabling the design of personalized medicine, and unlocking new frontiers in the treatment of various diseases. The integration of nanochemistry in the pharmaceutical field represents a transformative approach, fostering innovation and propelling the industry towards more effective and targeted therapeutic solutions.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia